Abstract:Background Drug safety in children is a major concern; however, there is still a lack of methods for quantitatively measuring, let alone to improving, drug safety in children under different clinical conditions. To assess pediatric drug safety under different clinical conditions, a computational method based on Electronic Medical Record (EMR) datasets was proposed. Methods In this study, a computational method was designed to extract the significant drug-diagnosis associations (based on a Bonferroni-adjusted hypergeometric P-value < 0.05) among drug and diagnosis co-occurrence in EMR datasets. This allows for differences between pediatric and adult drug use to be compared based on different EMR datasets. The drug-diagnosis associations were further used to generate drug clusters under specific clinical conditions using unsupervised clustering. A 5-layer quantitative pediatric drug safety level was proposed based on the drug safety statement of the pediatric labeling of each drug. Therefore, the drug safety levels under different pediatric clinical conditions were calculated. Two EMR datasets from a 1900-bed children's hospital and a 2000-bed general hospital were used to test this method. Results The comparison between the children's hospital and the general hospital showed unique features of pediatric drug use and identified the drug treatment gap between children and adults. In total, 591 drugs were used in the children's hospital; 18 drug clusters that were associated with certain clinical conditions were generated based on our method; and the quantitative drug safety levels of each drug cluster (under different clinical conditions) were calculated, analyzed, and visualized. Conclusion With this method, quantitative drug safety levels under certain clinical conditions in pediatric patients can be evaluated and compared. If there are longitudinal data, improvements can also be measured. This method has the potential to be used in many population-level, health data-based drug safety studies.

Design and statistical analysis reporting among interrupted time series studies in drug utilization research: a cross-sectional survey

Methodology and reporting characteristics of studies using interrupted time series design in healthcare

Assessing Health Care Interventions via an Interrupted Time Series Model: Study Power and Design Considerations

INTERRUPTED TIME SERIES DESIGNS IN HEALTH TECHNOLOGY ASSESSMENT: LESSONS FROM TWO SYSTEMATIC REVIEWS OF BEHAVIOR CHANGE STRATEGIES

A Robust Interrupted Time Series Model for Analyzing Complex Healthcare Intervention Data

Design, Analysis, Power, and Sample Size Calculation for Three-Phase Interrupted Time Series Analysis in Evaluation of Health Policy Interventions.

A Reanalysis of Cluster Randomized Trials Showed Interrupted Time-Series Studies Were Valuable in Health System Evaluation.

[Scan Statistic Theory and Its Application in Spatial Epidemiology].

Staggered interventions with no control groups

Interrupted Time-Series Analysis Yielded an Effect Estimate Concordant with the Cluster-Randomized Controlled Trial Result.

Interrupted Time Series Design and Analyses in Health Policy Assessment

Reporting, Handling, and Interpretation of Time-Varying Drug Treatments in Observational Studies Using Routinely Collected Healthcare Data.

A Computational Method to Quantitatively Measure Pediatric Drug Safety Using Electronic Medical Records

Using Simulation to Analyze Interrupted Time Series Designs

Survey and analysis on the statistical problem of medical postgraduates' dissertations

Reporting quality of randomized controlled trials of angina pectoris with integrated traditional Chinese and western medicine interventions: a cross-sectional study

Quantitative Safety Monitoring in Clinical Trials: Application of Multiple Statistical Methodologies for Infrequent Events

Development of a search filter to retrieve reports of interrupted time series studies from MEDLINE and PubMed

Sensitivity analysis in longitudinal clinical trials via distributional imputation

Missing data were poorly reported and handled in randomized controlled trials with repeatedly measured continuous outcomes: a cross-sectional survey

Using Data Mining to Analyze the Traffic Data of Intersection